Literature DB >> 33651098

Disruption of CSF-1R signaling inhibits growth of AML with inv(16).

Alexander Simonis1, Norman F Russkamp1, Jan Mueller1, C Matthias Wilk1, Mattheus H E Wildschut1,2, Renier Myburgh1, Nicole Wildner-Verhey van Wijk1, Rouven Mueller1, Stefan Balabanov1, Peter J M Valk3, Alexandre P A Theocharides1, Markus G Manz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33651098      PMCID： PMC7948293          DOI： 10.1182/bloodadvances.2020003125

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  14 in total

1.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

2.  inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice.

Authors:  Jana M Ellegast; Philipp J Rauch; Larisa V Kovtonyuk; Rouven Müller; Ulrich Wagner; Yasuyuki Saito; Nicole Wildner-Verhey van Wijk; Christine Fritz; Anahita Rafiei; Veronika Lysenko; Ewa Dudkiewicz; Alexandre P Theocharides; Davide Soldini; Jeroen S Goede; Richard A Flavell; Markus G Manz
Journal:  Blood       Date:  2016-08-31       Impact factor: 22.113

Review 3.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors:  Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2016-11-28       Impact factor: 22.113

4.  Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.

Authors:  Bas J Wouters; Bob Löwenberg; Claudia A J Erpelinck-Verschueren; Wim L J van Putten; Peter J M Valk; Ruud Delwel
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis.

Authors:  Michal Beffinger; Paulino Tallón de Lara; Sònia Tugues; Marijne Vermeer; Yannick Montagnolo; Isabel Ohs; Virginia Cecconi; Giulia Lucchiari; Aron Gagliardi; Nikola Misljencevic; James Sutton; Roman Spörri; Burkhard Becher; Anurag Gupta; Maries van den Broek
Journal:  JCI Insight       Date:  2018-05-17

Review 7.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

8.  CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.

Authors:  David K Edwards; Kevin Watanabe-Smith; Angela Rofelty; Alisa Damnernsawad; Ted Laderas; Adam Lamble; Evan F Lind; Andy Kaempf; Motomi Mori; Mara Rosenberg; Amanda d'Almeida; Nicola Long; Anupriya Agarwal; David Tyler Sweeney; Marc Loriaux; Shannon K McWeeney; Jeffrey W Tyner
Journal:  Blood       Date:  2018-11-13       Impact factor: 22.113

9.  Development and function of human innate immune cells in a humanized mouse model.

Authors:  Anthony Rongvaux; Tim Willinger; Jan Martinek; Till Strowig; Sofia V Gearty; Lino L Teichmann; Yasuyuki Saito; Florentina Marches; Stephanie Halene; A Karolina Palucka; Markus G Manz; Richard A Flavell
Journal:  Nat Biotechnol       Date:  2014-03-16       Impact factor: 54.908

Review 10.  Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.

Authors:  Michael A Cannarile; Martin Weisser; Wolfgang Jacob; Anna-Maria Jegg; Carola H Ries; Dominik Rüttinger
Journal:  J Immunother Cancer       Date:  2017-07-18       Impact factor: 13.751
View more
  1 in total

Review 1.  Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia.

Authors:  Kristine Yttersian Sletta; Oriol Castells; Bjørn Tore Gjertsen
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.